| Guidelines for the use and interpretation of assays for monitoring autophagy DJ Klionsky, K Abdelmohsen, A Abe, MJ Abedin, H Abeliovich, ... Autophagy 12 (1), 1-222, 2016 | 6922 | 2016 |
| Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes DJ Klionsky, H Abeliovich, P Agostinis, DK Agrawal, G Aliev, DS Askew, ... Autophagy 4 (2), 151-175, 2008 | 2450 | 2008 |
| To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery F Danhier, O Feron, V Préat Journal of controlled release 148 (2), 135-146, 2010 | 2032 | 2010 |
| Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice P Sonveaux, F Végran, T Schroeder, MC Wergin, J Verrax, ZN Rabbani, ... The Journal of clinical investigation 118 (12), 3930-3942, 2008 | 1280 | 2008 |
| Nitric oxide synthases: which, where, how, and why? T Michel, O Feron The Journal of clinical investigation 100 (9), 2146-2152, 1997 | 1188 | 1997 |
| Endothelial nitric oxide synthase targeting to caveolae specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells O Feron, L Belhassen, L Kobzik, TW Smith, RA Kelly, T Michel Journal of Biological Chemistry 271 (37), 22810-22814, 1996 | 782 | 1996 |
| Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin JB Michel, O Feron, D Sacks, T Michel Journal of Biological Chemistry 272 (25), 15583-15586, 1997 | 682 | 1997 |
| Nitric oxide and cardiac function: ten years after, and continuing PB Massion, O Feron, C Dessy, JL Balligand Circulation research 93 (5), 388-398, 2003 | 674 | 2003 |
| Hydroxy-methylglutaryl–coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance O Feron, C Dessy, JP Desager, JL Balligand Circulation 103 (1), 113-118, 2001 | 593 | 2001 |
| Paclitaxel-loaded PEGylated PLGA-based nanoparticles: in vitro and in vivo evaluation F Danhier, N Lecouturier, B Vroman, C Jérôme, J Marchand-Brynaert, ... Journal of controlled release 133 (1), 11-17, 2009 | 554 | 2009 |
| Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells O Feron Radiotherapy and oncology 92 (3), 329-333, 2009 | 506 | 2009 |
| Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis F Végran, R Boidot, C Michiels, P Sonveaux, O Feron Cancer research 71 (7), 2550-2560, 2011 | 504 | 2011 |
| eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues JL Balligand, O Feron, C Dessy Physiological reviews 89 (2), 481-534, 2009 | 478 | 2009 |
| Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase O Feron, C Dessy, S Moniotte, JP Desager, JL Balligand The Journal of clinical investigation 103 (6), 897-905, 1999 | 459 | 1999 |
| The endothelial nitric-oxide synthase-caveolin regulatory cycle O Feron, F Saldana, JB Michel, T Michel Journal of Biological Chemistry 273 (6), 3125-3128, 1998 | 436 | 1998 |
| Upregulation of β3-Adrenoceptors and Altered Contractile Response to Inotropic Amines in Human Failing Myocardium S Moniotte, L Kobzik, O Feron, JN Trochu, C Gauthier, JL Balligand Circulation 103 (12), 1649-1655, 2001 | 394 | 2001 |
| Caveolin versus calmodulin counterbalancing allosteric modulators of endothelial nitric oxide synthase JB Michel, O Feron, K Sase, P Prabhakar, T Michel Journal of Biological Chemistry 272 (41), 25907-25912, 1997 | 389 | 1997 |
| Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel F Danhier, B Vroman, N Lecouturier, N Crokart, V Pourcelle, H Freichels, ... Journal of Controlled Release 140 (2), 166-173, 2009 | 355 | 2009 |
| A roadmap for interpreting 13C metabolite labeling patterns from cells JM Buescher, MR Antoniewicz, LG Boros, SC Burgess, H Brunengraber, ... Current opinion in biotechnology 34, 189-201, 2015 | 341 | 2015 |
| Hsp90 and caveolin are key targets for the proangiogenic nitric oxide–mediated effects of statins A Brouet, P Sonveaux, C Dessy, S Moniotte, JL Balligand, O Feron Circulation research 89 (10), 866-873, 2001 | 336 | 2001 |
